Physician profile
Michael Steven Pollack
NPI 1558508978
$2,119.18
in general payments reported to CMS, 2019-2025
7 companies · $691 in 2025
The $691 reported for 2025 was more than what 85% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.58 · 2020: $180 · 2021: $23.97 · 2022: $115 · 2023: $619 · 2024: $440 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,749.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forestadent USA, INC. | $1,251.60 | 2022-2025 | |
| 3m Company | $275.63 | 2023 | 3m, Clarity Aligners, Transbond Plus |
| Align Technology, INC. | $218.79 | 2020-2025 | Invisalign |
| Solventum Corporation | $174.22 | 2025 | Clarity Aligners, Ortholux Luminous, Clarity Advanced |
| American Orthodontics Corporation | $131.97 | 2022-2024 | Radiance, Empower-Ceramic, LP and Ifit Tubes |
| Ormco Corporation | $50.58 | 2019 | |
| Envista Holdings Corporation | $16.39 | 2024 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.